BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38631387)

  • 1. Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers.
    Shevach JW; Candelieri-Surette D; Lynch JA; Hubbard RA; Alba PR; Glanz K; Parikh RB; Maxwell KN
    J Natl Compr Canc Netw; 2024 Apr; 22(4):237-243. PubMed ID: 38631387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems.
    Wadhwa A; Roscoe C; Duran EA; Kwan L; Haroldsen CL; Shelton JB; Cullen J; Knudsen BS; Rettig MB; Pyarajan S; Nickols NG; Maxwell KN; Yamoah K; Rose BS; Rebbeck TR; Iyer HS; Garraway IP
    JAMA Netw Open; 2024 Mar; 7(3):e242852. PubMed ID: 38502125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.
    Leopold C; Wagner AK; Zhang F; Lu CY; Earle C; Nekhlyudov L; Ross-Degnan D; Wharam JF
    Breast Cancer Res Treat; 2016 Jul; 158(2):333-40. PubMed ID: 27342456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
    Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
    Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.
    Sheinson DM; Wong WB; Meyer CS; Stergiopoulos S; Lofgren KT; Flores C; Adams DV; Fleury ME
    JAMA Netw Open; 2021 Dec; 4(12):e2138219. PubMed ID: 34882180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer.
    Borno HT; Odisho AY; Gunn CM; Pankowska M; Rider JR
    Urol Oncol; 2021 Apr; 39(4):233.e9-233.e14. PubMed ID: 33158741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer.
    Rasmussen KM; Patil V; Li C; Yong C; Appukkuttan S; Grossman JP; Jhaveri J; Halwani AS
    JAMA Netw Open; 2023 Oct; 6(10):e2337272. PubMed ID: 37819658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans.
    Valle LF; Nickols NG; Hausler R; Alba PR; Anglin-Foote T; Perez C; Yamoah K; Rose BS; Kelley MJ; DuVall SL; Garraway IP; Maxwell KN; Lynch JA
    Oncologist; 2023 Jun; 28(6):e473-e477. PubMed ID: 37084789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics.
    Ellis L; Canchola AJ; Spiegel D; Ladabaum U; Haile R; Gomez SL
    J Clin Oncol; 2018 Jan; 36(1):25-33. PubMed ID: 29035642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional variation in racial disparities among patients with peripheral artery disease.
    O'Donnell TFX; Powell C; Deery SE; Darling JD; Hughes K; Giles KA; Wang GJ; Schermerhorn ML
    J Vasc Surg; 2018 Aug; 68(2):519-526. PubMed ID: 29459014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying disparities in germline and somatic testing for ovarian cancer.
    Huang M; Kamath P; Schlumbrecht M; Miao F; Driscoll D; Oldak S; Slomovitz B; Koru-Sengul T; George S
    Gynecol Oncol; 2019 May; 153(2):297-303. PubMed ID: 30890269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
    Parikh RB; Robinson KW; Chhatre S; Medvedeva E; Cashy JP; Veera S; Bauml JM; Fojo T; Navathe AS; Malkowicz SB; Mamtani R; Jayadevappa R
    JAMA Netw Open; 2020 Sep; 3(9):e2018318. PubMed ID: 32986109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
    Rentsch CT; Kidwai-Khan F; Tate JP; Park LS; King JT; Skanderson M; Hauser RG; Schultze A; Jarvis CI; Holodniy M; Lo Re V; Akgün KM; Crothers K; Taddei TH; Freiberg MS; Justice AC
    PLoS Med; 2020 Sep; 17(9):e1003379. PubMed ID: 32960880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
    Ledet EM; Burgess EF; Sokolova AO; Jaeger EB; Hatton W; Moses M; Miller P; Cotogno P; Layton J; Barata P; Lewis BE; Nakazawa M; Zhu J; Dellinger B; Elrefai S; Nafissi NN; Egan JB; Shore N; McKay RR; Bryce AH; Cheng HH; Antonarakis ES; Sartor O
    Prostate; 2021 May; 81(7):433-439. PubMed ID: 33792945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.
    Davis BA; Aminawung JA; Abu-Khalaf MM; Evans SB; Su K; Mehta R; Wang SY; Gross CP
    J Natl Compr Canc Netw; 2017 Mar; 15(3):346-354. PubMed ID: 28275035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.